Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Immunovant, Inc. IMVT NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
47/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$35.67
+34.4%
Metric TTM (2025-03 – 2025-12)
Operating Cash Flow $-422.89M
Capital Expenditure $-201K
Free Cash Flow $-423.09M

People Also View

KRTX
KRTX
Karuna Therapeutics, Inc.
$329.83
+0.03%
 MDGL
MDGL
Madrigal Pharmaceuticals, Inc.
$524.99
-0.13%
 BPMC
BPMC
Blueprint Medicines Corporation
$129.46
+0.14%
 ACLX
ACLX
Arcellx, Inc.
$114.89
+0.02%
 PTGX
PTGX
Protagonist Therapeutics, Inc.
$104.72
+7.33%
 ISEE
ISEE
IVERIC bio, Inc.
$39.95
+0.38%
 APLS
APLS
Apellis Pharmaceuticals, Inc.
$40.85
+0.02%
 AKRO
AKRO
Akero Therapeutics, Inc.
$54.65
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message